CWA
FLNA

Carolina Wealth Advisors’s Filana Therapeutics FLNA Stock Holding History

Carolina Wealth Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-48
Closed -$1.41K – 341
2024
Q3 		$1.41K Hold
48
– – ﹤0.01% 292
2024
Q2 		$593 Hold
48
– – ﹤0.01% 207
2024
Q1 		$973 Hold
48
– – ﹤0.01% 200
2023
Q4 		$1.08K Hold
48
– – ﹤0.01% 219
2023
Q3 		$798 Hold
48
– – ﹤0.01% 241
2023
Q2 		$1.18K Hold
48
– – ﹤0.01% 222
2023
Q1 		$1.16K Hold
48
– – ﹤0.01% 232
2022
Q4 		$1K Hold
48
– – ﹤0.01% 220
2022
Q3 		$2K Buy
+48
New +$1.3K ﹤0.01% 217

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Carolina Wealth Advisors's FLNA Position: Q4 2024 in Review

Carolina Wealth Advisors sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 48 shares — an estimated $1.41K sold.

Carolina Wealth Advisors first reported a position in FLNA in Q3 2022 and held it in 9 quarters. The position peaked at $2K in Q3 2022. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Carolina Wealth Advisors reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Carolina Wealth Advisors sold 48 Filana Therapeutics shares in Q4 2024, an estimated $1.41K.
  • Carolina Wealth Advisors first reported a position in Filana Therapeutics in Q3 2022 and held it in 9 quarters.
  • Carolina Wealth Advisors's Filana Therapeutics position peaked at $2K in Q3 2022.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Carolina Wealth Advisors's 13F filing for Q4 2024, filed 14 Jan 2025.